Medical Research News

RSS

Eltrombopag studied in Idiopathic Thrombocytopenic Purpura

There are estimated to be between 50,000 -- 100,000 individuals in the U.S. diagnosed with chronic Immune Thrombocytopenic Purpura (ITP), an autoimmune disease that dramatically reduces the number of platelets in their blood -- causing bruises, nosebleeds and, sometimes, life-threatening brain hemorrhages.

29 Nov 2007

Could stem cells be used to cure Crohn's Disease?

Scientists are investigating whether stem cells could be used to 're-boot' the immune system and provide a cure for Crohn's Disease.

29 Nov 2007

The health risk posed by excessive CT scans

Scientists in the United States have expressed concern about the number of computed tomography or CT scans now being performed.

29 Nov 2007

How cells communicate focus of new research

Scientists at the University of Liverpool have been awarded £5 million to investigate how cells respond to stimuli such as stress and UV radiation.

27 Nov 2007

Researchers find evidence of mature heart cell potential in embryonic stem cells

In a new study, UC Davis researchers report the first functional evidence that heart cells derived from human embryonic stem cells exhibit one of the most critical properties of mature adult heart cells, an important biological process called excitation-contraction coupling.

27 Nov 2007

Discovery of novel pathway to increased inflammation in diabetes patients

Researchers at UC Davis Health System have discovered a novel pathway that results in increased inflammation of blood vessels in patients with type 1 diabetes.

27 Nov 2007

Stem cells train heart following heart attack

Following a heart attack, part of the heart tissue dies. It is still not possible to restore the scar tissue arising as a result of this. The majority of stem cell researchers attempt to make new heart muscle cells from stem cells.

27 Nov 2007

Discovery of gene responsible for statin-induced muscle pain

Statins, the popular class of drugs used to lower cholesterol, are among the most commonly prescribed medications in developed countries.

27 Nov 2007

Scientists adopt fresh approach in quest for new therapies

Scientists are to pool their expertise in human health to pioneer an innovative approach to treating common diseases.

27 Nov 2007

Researchers outline structure of largest nonvirus particle ever crystallized

Researchers at UCLA's California NanoSystems Institute, the David Geffen School of Medicine at UCLA and the Howard Hughes Medical Institute have modeled the structure of the largest cellular particle ever crystallized, suggesting ways to engineer the particles for drug delivery.

27 Nov 2007

Research suggests new direction for ALS treatment

A research team from Wake Forest University School of Medicine is the first to show that injections of a protein normally found in human cells can increase lifespan and delay the onset of symptoms in mice with ALS (amyotrophic lateral sclerosis), or Lou Gehrig's disease.

27 Nov 2007

RNA polymerase III mutation disrupts organ growth

The cellular mechanism that turns DNA into all of the thousands of proteins that make up a human body is itself both intricate and interesting.

27 Nov 2007

Brain stem-cell therapies more complicated than thought

An MIT research team's latest finding suggests that stem cell therapies for the brain could be much more complicated than previously thought.

27 Nov 2007

Discovery of key acute myeloid leukemia gene

A gene called N-Myc leads a double life in certain white blood cells, helping to trigger a cancer called acute myeloid leukemia (AML) under some conditions while triggering apoptosis, or cell suicide, under other conditions, according to results of a mouse study done by investigators at St. Jude Children's Research Hospital.

27 Nov 2007

Europe to tackle brain disorder research by linking industry, academia

Attempts to cure brain-related disorders have proved less successful than therapies for other major conditions such as heart cancer, even though just as many people suffer from them.

27 Nov 2007

Blood-vessel blocker aids cancer-killing virus

Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly move in and eliminate them.

27 Nov 2007

Australian stem cell scientist on target to prevent age-related loss of brain function

Stem cell scientists are developing a novel approach to slow or possibly prevent the cognitive decline that typically occurs with advancing age.

27 Nov 2007

Australian scientist awarded $1 million by Pfizer Australia to develop gene therapies for muscle-related diseases

An Australian scientist has been awarded a $1 million research grant to develop innovative gene therapy tools for muscle-related diseases.

27 Nov 2007

Red blood cell transfusions under scrutiny - research reveals potential harm

Bristol scientists have found that red blood cell transfusions given to people having heart surgery could increase the risk of heart attack or stroke.

27 Nov 2007

Researchers transfer immune response to myeloma patient

Researchers at the University of Arkansas for Medical Sciences (UAMS) have for the first time transferred an immune response in a healthy individual to a patient with multiple myeloma, a cancer of the bone marrow, showing promise for cancer vaccination.

27 Nov 2007